Sign In
Buy COGT
$32.26
-0.500 (-1.53%)
At Close: Jun 03, 2026
Emerald Advisers LLC Increases Stock Position in Cogent Biosciences, Inc. $COGT
04:53am, Thursday, 22'nd Jan 2026
Emerald Advisers LLC grew its holdings in shares of Cogent Biosciences, Inc. (NASDAQ: COGT) by 9.2% during the third quarter, according to the company in its most recent filing with the Securities and
Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR)
08:00am, Tuesday, 20'th Jan 2026
- PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus sunitinib combination demonstrating mPFS of 16.5 months and
Campbell & CO Investment Adviser LLC Purchases Shares of 61,634 Cogent Biosciences, Inc. $COGT
04:31am, Tuesday, 20'th Jan 2026
Campbell and CO Investment Adviser LLC acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ: COGT) during the undefined quarter, according to the company in its most recent 13F filing
Cogent Biosciences, Inc. (COGT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
05:15pm, Tuesday, 13'th Jan 2026
Cogent Biosciences, Inc. (COGT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
WALTHAM, Mass. and BOULDER, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically define
Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge
02:55pm, Sunday, 11'th Jan 2026
According to a Form 4, one Cogent Biosciences insider sold 65,000 shares of the biotech on Dec. 26 for a total value of $2.52 million. This sale represented 37.27% of Evan Kearns's direct holdings, as
Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 06'th Jan 2026
WALTHAM, Mass. and BOULDER, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically define
Cogent Biosciences Stock Soared in 2025. Four Executives Sold Shares on the Same Day.
11:44am, Friday, 02'nd Jan 2026
The biotech's chief legal and financial officers were among four executives who sold shares on the same day.
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis
08:00am, Tuesday, 30'th Dec 2025
WALTHAM, Mass. and BOULDER, Colo.
Squarepoint Ops LLC Purchases Shares of 101,518 Cogent Biosciences, Inc. $COGT
05:08am, Wednesday, 24'th Dec 2025
Squarepoint Ops LLC acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ: COGT) in the undefined quarter, according to the company in its most recent disclosure with the Securities an
Assenagon Asset Management S.A. Purchases 380,345 Shares of Cogent Biosciences, Inc. $COGT
03:44am, Sunday, 21'st Dec 2025
Assenagon Asset Management S.A. grew its holdings in shares of Cogent Biosciences, Inc. (NASDAQ: COGT) by 193.4% during the third quarter, according to the company in its most recent disclosure with t
Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank
09:26pm, Thursday, 11'th Dec 2025
Surprisingly, the Russell 2000 has a chance to be the second-best-performing index on the U.S. stock exchanges as we start to round out 2025, with the unprecedented push into small caps being inspired
Cogent Biosciences, Inc. (COGT) Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference Transcript
-- Bezuclastinib achieves clear clinical benefit across all symptom domains including significant improvements on 11 individual symptoms plus the most severe symptom at baseline -- -- Bezuclastinib
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
